Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BI 655075 Administered Alone or With Dabigatran Etexilate
Clinical trial NCT01688830 · COMPLETED
Trial details
- NCT number
- NCT01688830
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2013-11-01
- Enrollment
- 157
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.